Infinity Pharmaceuticals Inc (NASDAQ:INFI)
| 1.15 BATS BZX Real-Time Price As of 1:39pm ET |  -0.09 / -7.26%Today’s Change | 0.46 Today|||52-Week Range 3.34 | -48.89% Year-to-Date |
Latest INFI News | Press Releases
| Spectrum (SPPI) Down as FDA Panel Votes Against NSCLC Drug Sep 26 / Zacks.com - Paid Partner Content | Pacira's (PCRX) Label Expansion Study on Exparel Meets Goal Sep 22 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.24 |
| Today’s open | 1.18 |
| Day’s range | 1.12 - 1.18 |
| Volume | 3,222 |
| Average volume (3 months) | 663,285 |
| Market cap | $110.7M |
Data as of 1:39pm ET, 10/05/2022
Growth & Valuation
| Earnings growth (last year) | +21.83% |
| Earnings growth (this year) | +15.09% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +8.09% |
| P/E ratio | NM |
| Price/Sales | 103.66 |
| Price/Book | 5.13 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CLLSCellectis SA | -0.17 | -7.05% |
| IMUXImmunic Inc | +0.06 | +1.68% |
| ASRTAssertio Holdings In... | -0.00 | -0.22% |
| MNOVMediciNova Inc | -0.03 | -1.30% |
Data as of 1:41pm ET, 10/05/2022
Financials
| Next reporting date | November 8, 2022 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $1.9M |
| Annual profit (last year) | -$45.3M |
| Net profit margin | -2,436.06% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
